TACHYBEN®

Oxytocin is a drug that belongs to the group of medicines called oxytocins and it is identical with oxytocin, a hormone released by the pituitary gland, which has an effect on the muscles of the uterus (womb). Oxytocin EVER Pharma is a generic version of Syntocinon® (Novartis) and indicated for the induction of labour for medical reasons; stimulation of labour in hypotonic uterine inertia; during caesarean section, following delivery of the child; prevention and treatment of postpartum uterine atony and haemorrhage. Early stages of pregnancy as an adjunctive therapy for the management of incomplete, inevitable, or missed abortion. Currently registered in the UK and France with further registrations in progress or planned.

EVER Neuro Pharma GmbH offers a wide range of products which includes CEREBROLYSIN®. It is a biotechnologically prepared peptide that stimulates neurotrophic regulation in the central nervous system. It is used worldwide for treatment of ischemic and hemorrhagic stroke, traumatic brain injuries, to treat different forms of dementia (vascular dementia, Alzheimer's disease) and cognitive disorders and to prevent cognitive decline after brain injuries.contact us for more information.

EVER Neuro Pharma GmbH offers a wide range of products which includes DACEPTON®. It is used for treatment of movement disorders (“on-off” phenomena) in patients with Parkinson's disease and who cannot be effectively treated using oral anti-Parkinson medicine.contact us for more information.

Atosiban is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labour. Atosiban EVER is indicated1 to delay imminent pre-term birth in pregnant adult women with a gestational age from 24 until 33 completed weeks. Available as a convenient ready to use fixed dose (bolus injection) and fixed volumes concentrate for dilution (high dose/low dose infusions). Currently registered in 15 European countries, further registrations are in progress or planned globally. The product is indicated to delay imminent pre-term birth in pregnant adult women with: regular uterine contractions of at least 30 seconds duration at a rate of ≥ 4 per 30 minutes, a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥ 50%, a gestational age from 24 until 33 completed weeks, a normal foetal heart rate Ready to use product – either for immediate use or dilution for infusion. No reconstitution from powder required.Available in vials – safer and more convenient than ampoulesAvailable in 3 presentations – to cover loading, and high dose/low dose infusion administration stages

Fulvestrant EVER - Factsheet